CPE, CRE, CPO and CRABs! Jon Otter, PhD FRCPath Imperial College Hospitals NHS Trust Blog:

Slides:



Advertisements
Similar presentations
1. 2 Global Travel – who goes? 3 Global Links of NDM to the UK Kumarasamy et al., Lancet Infect Dis :
Advertisements

APIC Chapter 13 Journal Club April 15, 2015
Multidrug resistant organisms: What are we up against? Hans Jørn Kolmos MD DMSc Professor, consultant Department of Clinical Microbiology Odense University.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
What’s happening now ? Epidemiology of (carbapenem) resistance Neil Woodford HPA – AMRHAI - Colindale.
CARBAPENEM RESISTANT ENTEROBACTERIACEAE: RISK FACTORS AND ROLE OF EXTENDED CARE FACILITIES A. Makarem, MD; P. Alvarez, MD; T. Chou, MPH, CIC; M. Kulkarni,
Carbapenemase- Producing Carbapenem-Resistant Enterobacteriaceae Nicole Hearon, HAI Epidemiologist Surveillance and Investigation Division Indiana State.
Rising to the challenge of multidrug-resistant Gram-negative bacteria
Detecting CPE: time to throw away those agar plates?
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
European Centre for Disease Prevention and Control
Carbapenemases in practice - lessons learnt from spread in our patch, prophylaxis and first/second line treatments Dr Andrew Dodgson Consultant Microbiologist.
30mm 10mm logo safe area 10mm logo safe area EDITING NOTES All copy must stay within the content limit guidelines. Any image added to a slide with text.
Le infezioni batteriche nel paziente oncoematologico Corrado Girmenia Ematologia, Azienda Policlinico Umberto I Sapienza University of Rome, Italy Ematologia.
European approaches to MDR- GNR prevention and control Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust Blog:
Containing CRE spread Jon Otter, PhD FRCPath Scientific Director, Healthcare, Bioquell Research Fellow, King’s College London
30mm 10mm logo safe area 10mm logo safe area EDITING NOTES All copy must stay within the content limit guidelines. Any image added to a slide with text.
Part II High Priority Resistant Organisms. Healthcare Associated Infections NHSN Staphylococcus aureus (16%) 2.Enterococcus spp (14%) 3.Escherichia.
Anton Y. Peleg, M.B., B.S., M.P.H., and David C. Hooper, M.D. N Engl J Med 2010;362: Hospital-Acquired Infections Due to Gram-Negative Bacteria.
CRE/CPE/CRO: Demystifying the microbiology and opportunities for whole genome sequencing Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
My favourite papers on…environmental decontamination Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
Healthcare-Associated Infections and Infection Control
Carbapenem Resistant Enterobacteriaceae:
8th Annual Infection Prevention Conference 23rd June 2011, Harrogate
Alison Holmes, Jonathan Otter
The growing dangers around CPE
CRE prevalence among patients with no prior history of carriage
Professor Alan Johnson Department of HCAI & AMR
Jon Otter, PhD FRCPath Imperial College London @jonotter Blog:
Screening for CPE: sensitivity of serial admission screens
CPE screening: seek and ye shall find!
Rising to the challenge of multidrug-resistant Gram-negative bacteria
Who’s carrying CPE? Universal admission screening in London
Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford,
IPC – new, novel, and exciting
GNBSI Can we really halve GNBSIs? Jon Otter, PhD FRCPath
Antibiotics: handle with care!
Introduction to epidemiology (and infection)
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Counting the cost of controlling an outbreak of CPE: an economic evaluation Jonathan A. Otter,1,2 Philip Burgess,3 Frances Davies,2 Siddharth Mookerjee,2.
Nine decades of antibiotics: how many years of antibiotic resistance?
The ‘bed location lottery’: the MDRO status of the prior bed occupant affects the risk of acquisition Jon Otter, PhD Scientific Director, Healthcare, Bioquell.
Promiscuous plasmids? Scaling infection control implications of horizontal spread of carbapenemase genes between species Siddharth Mookerjee, Frances Davies,
Using the Toolkit to build a CPE policy
Main modes of transmission CPE
Coping with multiresistant bacteria in the ICU
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Counting the cost and value of hospital cleaning and disinfection
Carbapenem-resistant Gram-negative bacteria
From hospital microbiome to new answers for environmental cleaning
Cost utility of alternative Carbapenemase
The role of environmental surfaces in disease transmission
Overseas travel and antibiotic use are more important than community demographics or measures of social and material deprivation in predicting ESBL colonization.
SUPERBUGS: STRUMENTI DI INTERVENTO NELL’ERA POST-ANTIBIOTICA
Measuring and improving compliance with risk-factor based CPE admission screening Siddharth Mookerjee,1 Kate Martin, 1 Itziar Atucha-Zambrano, 1 Rebecca.
AMR: a clinical perspective
CPE: coming to a hospital near you!
Promoting a Public Health Approach to Detecting and Containing Novel and Emergent Antibiotic Resistant Organisms Maroya Walters, PhD, ScM Division of Healthcare.
Hospital cleaning and disinfection: we can do better!
Hospital Acquired Infections
Removal of sinks from ICU Patient rooms
The management of CPE outbreaks panel
Implementing innovation when financial times are hard
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
An introduction to infectious diseases epidemiology
Fighting MDR G-Negative Infections
Belinda Ostrowsky, MD, MPH Field Medical Officer, NY
Presentation transcript:

CPE, CRE, CPO and CRABs! Jon Otter, PhD FRCPath Imperial College Hospitals NHS Trust Blog: You can download these slides from

THE END OF ANTIBIOTICS IS NIGH

“CRE are nightmare bacteria.” Dr Tom Frieden, CDC Director “If we don't take action, then we may all be back in an almost 19th Century environment where infections kill us as a result of routine operations.” Dame Sally Davies, Chief Medical Officer “If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine where treatable infections and injuries will kill once again.” David Cameron, Prime Minister, UK “The rise of antibiotic-resistant bacteria, however, represents a serious threat to public health and the economy.” Barack Obama, President USA What’s the problem?

Rising threat from MDR-GNR % of all HAI caused by GNRs. Hidron et al. Infect Control Hosp Epidemiol 2008;29: Peleg & Hooper. N Engl J Med 2010;362: % of ICU HAI caused by GNRs. Non-fermentersAcinetobacter baumannii Pseudomonas aeruginosa Stenotrophomonas maltophilia EnterobacteriaceaeKlebsiella pneumoniae Escherichia coli Enterobacter cloacae CPE CPO

ShareDiffer Gram stain reactionRisk factors & at-risk population Concerning AMRPotential for epidemic spread Infection profile & mortality Prevalence Colonisation site & duration Transmission routes Resistance profile & mechanisms Enterobacteriaceae vs. non-fermenters

What’s the problem? Resistance Courtesy of Pat Cattini

EnterobacteriaceaeNon fermenters OrganismAmpC / ESBLCREA. baumannii Attributable mortality ModerateMassive (>50%)Minimal Shorr et al. Crit Care Med 2009;37: Patel et al. Iinfect Control Hosp Epidemiol 2008;29: What’s the problem? Mortality

What’s the problem? Rapid spread Rapid spread Clonal expansion GI carriage Horizontal gene transfer

Acronym minefield MDR-GNR MDR-GNB CRO CPE CPC CRC CRAB ESBL KPC

What are CPE? Carbapenem-resistant Enterobacteriaceae (CRE) – Enterobacteriaceae that are resistant to carbapenems by any mechanism. Carbapenemase-producing Enterobacteriaceae (CPE) – Enterobacteriaceae that are resistant to carbapenems by means of an acquired carbapenemase. CRE CPE

When CPE is not CRE Courtesy of Dr Katie Hopkins, PHE. Carbapenem MIC N Wild-type Carbapenemase ESBL / AmpC + porin loss or true carbapenemase ?

Understanding the enemy PathogenCPE 1 CPAB 2 MRSAVREC. difficile Resistance /- Resistance genes Multiple Single n/a SpeciesMultipleSingle HA vs CAHA & CAHA (ICU)HA At-risk ptsAllICUUnwell Old Virulence++++/-+++/-+ Environment+/ Carbapenemase-producing Enterobacteriaceae. 2.Carbapenemase-producing Acinetobacter baumannii.

NHSN / NNIS data; MMWR 2013;62: CRE in the USA

Lin et al. Clin Infect Dis 2013;57: CRE in LTACs, USA

Carbapenem-resistant organisms, Europe EARS-Net

Colistin resistance in Italy Monaco et al. 2014; Euro Surveill 2014;19:pii= Survey of 191 CPE from 21 labs across Italy. 43% Colistin resistant K. pneumoniae. Range = 10-80% for the 21 labs.

Emergence of CPE in the UK PHE.

CPE in the UK and US

Evidence-free zone

Guidelines = Policy

MDR- GNR Toolbox Hand hygiene Cleaning / disinfection HCW screening Decol. Cohorting staff / patients Note flaggingEducation Env. screening Contact precautions Active screening Antibiotic stewardship Otter et al. Clin Microbiol Infect 2015 in press.

Cataldo et al. ECCMID Typen studiesFailure rateOdds ratio Bundled intervention7528% 1.9 Single intervention1145%

What works? Israel Schwaber et al. Clin Infect Dis 2011;52: * Physical segregation of CRE carriers; cohorted staff; appointed taskforce. *

Summary 1.MDR-GNR are emerging worldwide and represent a unique threat. 2.CPE in particular combine resistance, virulence and the potential for rapid spread. 3.Prevalence in the US appears to be patchy, but increasing. 4.We do not yet know what is effective in terms of prevention and control, but screening and isolation of carriers seems prudent. 5.We need to be singing from the same acronym hymnsheet!

CPE, CRE, CPO and CRABs! Jon Otter, PhD FRCPath Imperial College Hospitals NHS Trust Blog: You can download these slides from